Verisk Analytics, Inc. (VRSK) Stock Analysis
Is VRSK a good investment?
Verisk Analytics, Inc. (VRSK) has a Plutrex AI rating of 56.0/100 as of November 09, 2026, indicating a Hold consensus. The stock is halal-compliant per AAOIFI standards. Key strength: Elite profitability moat — operating margin 45.2% (135% above industry average 19.2%), net margin 27.7% (vs. near-zero industry), FCF $1.1B annually — a near-monopoly in insurance analytics with high switching costs and recurring subscription revenues that peers cannot replicate; Q3 results ('Verisk Analytics (VRSK) Surpasses Q3 Earnings and Revenue Estimates') reinforce the durability of this model with EPS $1.96 beating $1.92 consensus. Main concern: Valuation continues to deteriorate with every passing week — PEG 2.85x (up from 2.75x prior, up from 2.51x two reports ago), analyst consensus target FELL from $228 to $221 to current $221, upside compressed from 30.4% to 16.4% to current 8.0%. Stock at $204.59 is now 4.4% more expensive than 14 days ago with zero fundamental improvement; DCF intrinsic value $150-$170 implies 17-27% downside; paying a 28.3% PEG premium for a business growing at half the peer rate is mathematically unjustifiable.
Investment Summary
VRSK is a world-class data franchise with extraordinary profitability metrics — operating margin 45.2% (135% above industry average of 19.2%), net margin 27.7% (vs. near-zero industry average), and $1.1B in annual free cash flow — but the stock continues to drift further into overvalued territory with each passing day. At $204.59, the PEG ratio has now risen to 2.85x (up from 2.75x two weeks ago), 28.3% above the peer average of 2.22x, while the analyst consensus target has FALLEN from $228 to $221, compressing upside to just 8.0% from 16.4%. The P/E of 31.03x on a business growing revenue at only 5.3% annually (vs. industry 7.9%) and 5-year EPS at 10.9% (vs. industry 18.6%) leaves no margin of safety. Q3 results were solid — EPS of $1.96 beat consensus of $1.92 by 2.1%, revenue grew 5% YoY on subscription strength — but represent exactly the moderate, predictable performance already priced into the stock. The stock is now 4.4% more expensive than 14 days ago with ZERO fundamental improvement and a deteriorating analyst target. DO NOT CHASE.
Key Strengths
- Elite profitability moat — operating margin 45.2% (135% above industry average 19.2%), net margin 27.7% (vs. near-zero industry), FCF $1.1B annually — a near-monopoly in insurance analytics with high switching costs and recurring subscription revenues that peers cannot replicate; Q3 results ('Verisk Analytics (VRSK) Surpasses Q3 Earnings and Revenue Estimates') reinforce the durability of this model with EPS $1.96 beating $1.92 consensus
- Subscription model resilience — 'Revenue increased 5% year-over-year driven by strong subscription growth' confirms recurring revenue base with high customer retention; catastrophe loss estimation publications ('Verisk's Catastrophe and Risk Solutions business estimates Hurricane Isaias insured industry losses between $1-2B') reinforce Verisk's authoritative market position and validate the brand premium that underpins pricing power
- Forward EPS acceleration — Next Year EPS growth 12.8% represents acceleration above historical YoY EPS growth of 9.2%, suggesting margin expansion and buyback accretion are delivering forward earnings growth even on a modest 5.3% revenue base
Key Concerns
- Valuation continues to deteriorate with every passing week — PEG 2.85x (up from 2.75x prior, up from 2.51x two reports ago), analyst consensus target FELL from $228 to $221 to current $221, upside compressed from 30.4% to 16.4% to current 8.0%. Stock at $204.59 is now 4.4% more expensive than 14 days ago with zero fundamental improvement; DCF intrinsic value $150-$170 implies 17-27% downside; paying a 28.3% PEG premium for a business growing at half the peer rate is mathematically unjustifiable
- AccuLynx acquisition overhang remains unresolved — forced acquisition at ~$2.35B (~2.1x annual FCF of $1.1B) would materially increase gross debt on an already-negative-equity balance sheet, divert FCF from buybacks (the primary EPS growth engine), introduce integration execution risk, and compress the buyback-driven EPS accretion that justifies the forward growth premium; this binary risk remains the single largest unpriced downside catalyst
Plutrex 10-Factor AI Breakdown
Fundamental Analysis
VRSK's fundamentals present a classic 'magnificent business, wrong price' scenario. PROFITABILITY: Gross margin 59.9%, operating margin 45.2% (vs. industry 19.2%), net margin 27.7% (vs. industry 0.21%), ROE 444% (inflated by negative book equity from buybacks vs. industry average -17.3%). FCF $1.1B confirms real cash generation. HEALTH: Cash $557.6M adequate; D/E N/A due to negative book equity — structural leverage is real and unquantifiable conventionally. GROWTH: This is the critical weakness — revenue growth 5.3% (vs. peers 7.9%), trailing EPS growth 5.4% (vs. peers 9.3%), forward 1-year EPS 12.9% (vs. peers 29.5%), forward 5-year EPS 10.9% (vs. peers 18.6%). VRSK grows at roughly half the rate of its software peers across every growth dimension. VALUATION: P/E 31.03x (slight 9.5% discount to peer average 34.3x), BUT PEG 2.85x (28.3% PREMIUM to peer average 2.22x) — headline P/E looks cheap vs. peers, but growth-adjusted, it's the most expensive name in the group. DCF intrinsic value using $1.1B FCF at 10.9% growth for 5 years then 5% perpetuity at 10% discount rate yields $150-$170 — implying 17-27% downside from $204.59. Analyst consensus target $221 implies only 8.0% upside.
News Sentiment
Verisk Analytics delivered a steady — if unspectacular — performance in its latest earnings report, reinforcing its reputation as one of insurance's most reliable data partners while doing little to justify the stock's premium price tag. The company reported third-quarter earnings of $1.96 per share, edging past the Wall Street consensus estimate of $1.92 — a modest 2.1% beat that headline writers celebrated with 'Verisk Analytics (VRSK) Surpasses Q3 Earnings and Revenue Estimates.' Revenue climbed 5% year-over-year, powered by what the company calls its subscription engine — the recurring, high-retention revenue streams that make Verisk's business model the envy of the analytics world. Behind the scenes, Verisk's Catastrophe and Risk Solutions unit made headlines for a different reason: its authoritative estimate that Hurricane Isaias caused between $1 billion and $2 billion in insured industry losses for onshore property. That kind of real-time catastrophe intelligence — published as insurers scramble to quantify their exposure — is the living proof of why Verisk's clients cannot afford to cancel their subscriptions. 'What Verisk Analytics Said on Its Q3 Earnings Call' revealed management's continued focus on data-driven subscription growth. The bottom line for investors: Verisk is executing exactly as advertised — steady, profitable, essential to global insurance markets. The challenge isn't the business; it's the price. At $204.59, with the analyst target now at $221 and only 8% upside on the table, perfection is already baked in.
Risk Assessment
PRIMARY RISK: Valuation — at $204.59, PEG 2.85x implies significant downside (17-27% per DCF to $150-$170 intrinsic value) if growth disappoints or market re-rates software multiples lower. SECONDARY RISK: AccuLynx acquisition (~$2.35B, ~2.1x FCF) if executed would force debt increase on negative-equity balance sheet, divert FCF from buybacks (the EPS growth engine), and introduce integration risk — this is an unresolved binary overhang that continues to suppress the conviction ceiling. THIRD RISK: Analyst target trajectory is DECLINING (from $231.60 → $228 → $221), not rising — this is a warning signal that institutional expectations are being revised lower even as the stock price rises. MITIGATION: VRSK's $1.1B FCF provides debt service cushion; subscription model provides revenue floor; catastrophe analytics franchise is essentially irreplaceable. For existing holders: HOLD, do not add. For new entrants: WAIT for $175-$183 entry zone. At $179 midpoint vs. $221 analyst target = +$42 = +23.5% upside; stop at $164 = -$15 = -8.4% downside; R/R = 2.8x. With AccuLynx resolution adding further downside risk, $164 stop respects both technical support and binary event risk.
Related Halal Stocks
Related Stocks
Frequently Asked Questions
Is VRSK a halal stock?
Yes, Verisk Analytics, Inc. (VRSK) is halal-compliant per AAOIFI standards as of the latest quarterly review.
What is Plutrex's AI rating for VRSK?
Verisk Analytics, Inc. (VRSK) has a Plutrex AI rating of 56.0/100 with a Hold consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.
Is VRSK a good investment?
According to Plutrex AI, VRSK has a Hold rating (56.0/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.
How can I invest in VRSK?
US stocks like VRSK can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. ElBarake provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.
What are the main risks of investing in VRSK?
Plutrex AI identifies the main risks for VRSK by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.